Showing results (11-20 of 76) with videos related to
Sort By:
Pageof 8
Cytotherapy|January 19, 2019
T-cell receptor gene-modified cells: past promises, present methodologies and future challengesRita Tendeiro Rego, Emma C Morris, Mark W LowdellBritish Journal of Haematology|October 10, 2012
Successful isolation and expansion of CMV-reactive T cells from G-CSF mobilized donors that retain a strong cytotoxic effector functionEdward R Samuel, Katy Newton, Stephen Mackinnon, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 13, 2004
Antiviral immunity and T-regulatory cell function are retained after selective alloreactive T-cell depletion in both the HLA-identical and HLA-mismatched settingsJeffrey K Davies, Mickey B c Koh, Mark W LowdellCytometry. Part B, Clinical Cytometry|August 24, 2012
Improved accuracy and reproducibility of enumeration of platelet-monocyte complexes through use of doublet-discriminator strategyBikash Majumder, Janet North, Chrysostomos Mavroudis, et al.Expert Opinion on Biological Therapy|March 18, 2017
Decellularized material as scaffolds for tissue engineering studies in long gap esophageal atresiaEsmond Lee, Anna Milan, Luca Urbani, et al.Cytotherapy|June 24, 2014
Manufacturing of highly functional and specific T cells for adoptive immunotherapy against virus from granulocyte colony-stimulating factor-mobilized donorsLorea Beloki, Natalia Ramírez, Eduardo Olavarría, et al.Plos One|January 28, 2014
Isolation of highly suppressive CD25+FoxP3+ T regulatory cells from G-CSF-mobilized donors with retention of cytotoxic anti-viral CTLs: application for multi-functional immunotherapy post stem cell transplantationEdward R Samuel, Lorea Beloki, Katy Newton, et al.Cytotherapy|December 2, 2020
Human umbilical cord mesenchymal stromal cells as an adjunct therapy with therapeutic hypothermia in a piglet model of perinatal asphyxiaNicola J Robertson, Christopher Meehan, Kathryn A Martinello, et al.Cytotherapy|April 22, 2017
Natural killer cells differentiated in vitro from cord blood CD34+ cells are more advantageous for use as an immunotherapy than peripheral blood and cord blood natural killer cellsAnna Domogala, Michael Blundell, Adrian Thrasher, et al.Scientific Reports|June 12, 2021
GMP compliant isolation of mucosal epithelial cells and fibroblasts from biopsy samples for clinical tissue engineeringAngela Tait, Toby Proctor, Nick J I Hamilton, et al.Pageof 8